Trends in Patents in Life Sciences: focus on Pharmaceuticals and Medical Technologies

Nicola Grassano and Robert M'barek
Additional contact information
Robert M'barek: European Commission - JRC, https://joint-research-centre.ec.europa.eu/index_en

No JRC142609, JRC Research Reports from Joint Research Centre

Abstract: Pharmaceuticals and Medical Technologies (PMTs) patents represent 12.6% of the total IP5 patent families filed worldwide in the period 2010-2020. The US are the biggest player in the field, filing 25.1% of all PMTs IP5 patent families 2010-2020. The EU is second with 17.2%, followed by Japan (8.5%), South Korea (4.4%) and China (3.2%). Among EU Member States, Germany has by far the highest number of PMTs IP5 patent families filed in the observed period, accounting for 36% of all the patents filed by the EU 2010-2020.

Date: 2025-06
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://publications.jrc.ec.europa.eu/repository/handle/JRC142609 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ipt:iptwpa:jrc142609

Access Statistics for this paper

More papers in JRC Research Reports from Joint Research Centre Contact information at EDIRC.
Bibliographic data for series maintained by Publication Officer ().